Announcements Trials

Browse Landscape

Phase

Status

Recruiting 19 Unknown 14 Not yet recruiting 12 Active not recruiting 2 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 9 Standard of Care 6 Educational Status 6 Nivolumab 5 Interviews as Topic 5 Carboplatin 5 Radiotherapy 4 Paclitaxel 4 Oxaliplatin 4 Fluorodeoxyglucose F18 4 Dexamethasone 4 pembrolizumab 3 camrelizumab 3 Practice Guidelines as Topic 3 Patient Navigation 3 Methods 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Lenalidomide 3 Fluorouracil 3 Exercise 3 Early Intervention, Educational 3 Drug Therapy 3 Cytarabine 3 130-nm albumin-bound paclitaxel 3 venetoclax 2 toripalimab 2 tislelizumab 2 sacituzumab govitecan 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × dalpiciclib × Clear all

NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡